.png){kind=icon}
返回
Neutralizing Antibody Sample Testing and Report Harmonization
.png){kind=icon}
OA
AI
DOI：10.1208/s12248-024-00955-1.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Immunogenicity testing and characterization is an important part of understanding the immune response to administration of a protein therapeutic. Neutralizing antibody (NAb) assays are used to characterize a positive anti-drug antibody (ADA) response. Harmonization of reporting of NAb assay performance and results enables efficient communication and expedient review by industry and health authorities. Herein, a cross-industry group of NAb assay experts have harmonized NAb assay reporting recommendations and provided a bioanalytical report (BAR) submission editable template developed to facilitate agency filings. This document addresses key bioanalytical reporting gaps and provides a report structure for documenting clinical NAb assay performance and results. This publication focuses on the content and presentation of the NAb sample analysis report including essential elements such as the method, critical reagents and equipment, data analysis, study samples, and results. The interpretation of immunogenicity data, including the evaluation of the impact of NAb on safety, exposure, and efficacy, is out of scope of this publication.
Keyword:
bioanalytical report
immunogenicity
multi-functional therapeutics
neutralizing antibody
template
期刊
IF:
3.7
论文数:
2.3K
被引数:
7.5K
机构
查看更多机构
引用论文
Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides-Harmonized Terminology and Tactical Recommendations.png)
AAPS JOURNALOAAI
AAPS JOURNALIF3.7
OAAI分享收藏分享收藏Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay DriftAAPS JOURNAL
OAAI
AAPS JOURNALIF3.7
OAAI分享收藏Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics用于检测针对生物疗法引起的中和抗体免疫反应的基于细胞的测定的验证建议
PREAI
分享收藏 查看更多内容